東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/07/21 | 1,742 | 1,752 | 1,727 | 1,749 | +24 | +1.4% | 180,100 |
2023/07/20 | 1,756 | 1,756 | 1,720 | 1,725 | -31 | -1.8% | 188,300 |
2023/07/19 | 1,755 | 1,758 | 1,744 | 1,756 | +12 | +0.7% | 113,300 |
2023/07/18 | 1,730 | 1,744 | 1,728 | 1,744 | +14 | +0.8% | 117,500 |
2023/07/14 | 1,718 | 1,736 | 1,718 | 1,730 | +12 | +0.7% | 140,300 |
2023/07/13 | 1,714 | 1,732 | 1,711 | 1,718 | +3 | +0.2% | 111,400 |
2023/07/12 | 1,714 | 1,719 | 1,703 | 1,715 | +2 | +0.1% | 150,000 |
2023/07/11 | 1,717 | 1,726 | 1,711 | 1,713 | -14 | -0.8% | 195,900 |
2023/07/10 | 1,730 | 1,738 | 1,724 | 1,727 | -10 | -0.6% | 141,500 |
2023/07/07 | 1,747 | 1,747 | 1,726 | 1,737 | -22 | -1.3% | 154,900 |
2023/07/06 | 1,763 | 1,769 | 1,755 | 1,759 | -4 | -0.2% | 143,900 |
2023/07/05 | 1,754 | 1,766 | 1,748 | 1,763 | -2 | -0.1% | 152,300 |
2023/07/04 | 1,780 | 1,784 | 1,763 | 1,765 | -25 | -1.4% | 139,500 |
2023/07/03 | 1,778 | 1,802 | 1,778 | 1,790 | +19 | +1.1% | 96,800 |
2023/06/30 | 1,794 | 1,794 | 1,769 | 1,771 | -29 | -1.6% | 141,300 |
2023/06/29 | 1,815 | 1,824 | 1,796 | 1,800 | -21 | -1.2% | 107,400 |
2023/06/28 | 1,802 | 1,821 | 1,800 | 1,821 | +19 | +1.1% | 105,800 |
2023/06/27 | 1,821 | 1,826 | 1,792 | 1,802 | -27 | -1.5% | 91,400 |
2023/06/26 | 1,823 | 1,835 | 1,808 | 1,829 | +6 | +0.3% | 84,900 |
2023/06/23 | 1,832 | 1,837 | 1,812 | 1,823 | +2 | +0.1% | 122,300 |
2023/06/22 | 1,815 | 1,827 | 1,813 | 1,821 | +11 | +0.6% | 177,900 |
2023/06/21 | 1,806 | 1,820 | 1,805 | 1,810 | +1 | +0.1% | 77,200 |
2023/06/20 | 1,810 | 1,813 | 1,795 | 1,809 | +2 | +0.1% | 107,100 |
2023/06/19 | 1,792 | 1,827 | 1,792 | 1,807 | +26 | +1.5% | 153,800 |
2023/06/16 | 1,763 | 1,786 | 1,757 | 1,781 | +18 | +1% | 176,300 |
2023/06/15 | 1,776 | 1,776 | 1,760 | 1,763 | -15 | -0.8% | 135,200 |
2023/06/14 | 1,788 | 1,792 | 1,775 | 1,778 | -8 | -0.4% | 114,000 |
2023/06/13 | 1,804 | 1,813 | 1,784 | 1,786 | -14 | -0.8% | 101,300 |
2023/06/12 | 1,800 | 1,808 | 1,797 | 1,800 | +3 | +0.2% | 74,900 |
2023/06/09 | 1,788 | 1,804 | 1,784 | 1,797 | +12 | +0.7% | 103,600 |
2023/06/08 | 1,797 | 1,797 | 1,774 | 1,785 | +7 | +0.4% | 74,800 |
2023/06/07 | 1,786 | 1,817 | 1,778 | 1,778 | -2 | -0.1% | 173,500 |
2023/06/06 | 1,764 | 1,780 | 1,747 | 1,780 | +9 | +0.5% | 127,700 |
2023/06/05 | 1,801 | 1,801 | 1,767 | 1,771 | +7 | +0.4% | 143,100 |
2023/06/02 | 1,733 | 1,764 | 1,728 | 1,764 | +40 | +2.3% | 99,200 |
2023/06/01 | 1,751 | 1,774 | 1,723 | 1,724 | -31 | -1.8% | 203,700 |
2023/05/31 | 1,803 | 1,806 | 1,754 | 1,755 | -62 | -3.4% | 206,300 |
2023/05/30 | 1,853 | 1,856 | 1,813 | 1,817 | -29 | -1.6% | 135,500 |
2023/05/29 | 1,850 | 1,860 | 1,840 | 1,846 | -10 | -0.5% | 106,800 |
2023/05/26 | 1,870 | 1,870 | 1,849 | 1,856 | -6 | -0.3% | 106,100 |
2023/05/25 | 1,891 | 1,891 | 1,861 | 1,862 | -31 | -1.6% | 106,000 |
2023/05/24 | 1,914 | 1,914 | 1,892 | 1,893 | -13 | -0.7% | 69,200 |
2023/05/23 | 1,929 | 1,933 | 1,898 | 1,906 | -9 | -0.5% | 84,500 |
2023/05/22 | 1,903 | 1,919 | 1,896 | 1,915 | ±0 | ±0% | 120,800 |
2023/05/19 | 1,939 | 1,939 | 1,906 | 1,915 | -19 | -1% | 77,100 |
2023/05/18 | 1,954 | 1,954 | 1,933 | 1,934 | -2 | -0.1% | 85,000 |
2023/05/17 | 1,990 | 1,993 | 1,935 | 1,936 | -48 | -2.4% | 108,100 |
2023/05/16 | 1,940 | 1,993 | 1,938 | 1,984 | +79 | +4.1% | 207,100 |
2023/05/15 | 1,915 | 1,919 | 1,899 | 1,905 | +7 | +0.4% | 84,600 |
2023/05/12 | 1,906 | 1,915 | 1,885 | 1,898 | -18 | -0.9% | 101,200 |
201~
250
件表示中 / 6710件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 276,200円 | +14.7% | -28.1% | 2.17% | 11.72倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 344,400円 | +4.2% | -21.6% | 4.36% | 23.29倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 316,500円 | +9.8% | -12.1% | 2.84% | 12.38倍 | 0.63倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 34,000円 | +7.5% | - | 0.00% | - | 0.87倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ネクセラファーマ | 147,100円 | +150.7% | - | 0.00% | 37.79倍 | 1.98倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム